These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Acromegaly. I. Diagnostic use of radioimmunological determination of the somatotropic hormone]. Marek J; Srámková J; Bleha O; Engelberth O Cas Lek Cesk; 1973; 112(24):745-50. PubMed ID: 4714502 [No Abstract] [Full Text] [Related]
28. Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study. Caron P; Brue T; Raverot G; Tabarin A; Cailleux A; Delemer B; Renoult PP; Houchard A; Elaraki F; Chanson P Endocrine; 2019 Jan; 63(1):120-129. PubMed ID: 30269264 [TBL] [Abstract][Full Text] [Related]
29. Clinical manifestations of acromegaly. Molitch ME Endocrinol Metab Clin North Am; 1992 Sep; 21(3):597-614. PubMed ID: 1521514 [TBL] [Abstract][Full Text] [Related]
30. Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery. Brockmeier SJ; Buchfelder M; Adams EF; Schott W; Fahlbusch R Horm Metab Res; 1992 Aug; 24(8):392-400. PubMed ID: 1526628 [TBL] [Abstract][Full Text] [Related]
31. [Determination of growth hormone response to thyreoliberin in the evaluation of lisuride therapy of acromegaly]. Felt V; Nedvídková J Vnitr Lek; 1982 Aug; 28(8):756-61. PubMed ID: 6814061 [No Abstract] [Full Text] [Related]
32. Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly. Wass JA J Endocrinol; 1997 Oct; 155 Suppl 1():S17-9; discussion S21. PubMed ID: 9389991 [TBL] [Abstract][Full Text] [Related]
33. Spontaneous burned-out acromegaly with preservation of normal human growth hormone responses: diagnostic, historical, theoretical, and treatment aspects. Ewer RW; Kotheimer TG Johns Hopkins Med J; 1970 Oct; 127(4):199-212. PubMed ID: 4320105 [No Abstract] [Full Text] [Related]
35. Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. Mazziotti G; Bonadonna S; Doga M; Patelli I; Gazzaruso C; Solerte SB; De Menis E; Giustina A Neuroendocrinology; 2008; 88(4):299-304. PubMed ID: 18617732 [TBL] [Abstract][Full Text] [Related]
36. Radiogrammetry of the soft tissue at the index finger in acromegaly. Dequeker J; Geussens P; De Proft G; Bouillon R Clin Radiol; 1979 Sep; 30(5):517-9. PubMed ID: 466955 [TBL] [Abstract][Full Text] [Related]
37. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy. Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923 [TBL] [Abstract][Full Text] [Related]
38. [Isodensigraphic contribution to X-ray diagnosis of acromegaly (author's transl)]. Balcar V; Silinková-Málková E; Marek J; Pacovský V Sb Lek; 1977 Aug; 79(7-8):223-5. PubMed ID: 905760 [No Abstract] [Full Text] [Related]
39. Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis. Placzek H; Xu Y; Mu Y; Begelman SM; Fisher M J Manag Care Spec Pharm; 2015 Dec; 21(12):1106-12. PubMed ID: 26679960 [TBL] [Abstract][Full Text] [Related]